The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1/2, open label study of amivantamab in combination with tyrosine kinase inhibitors among participants with advanced NSCLC harboring ALK, ROS1, and RET gene fusions.
 
Tejas Patil
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb Foundation; Daiichi Sankyo/Astra Zeneca; Elevation Oncology; Janssen; Jazz Pharmaceuticals; Mirati Therapeutics; Pfizer; Regeneron; Takeda; Turning Point Therapeutics
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Gilead Sciences (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Takeda
 
Anne C Martin
No Relationships to Disclose
 
Haley K Wise
No Relationships to Disclose
 
Emily Schmitt
No Relationships to Disclose
 
Halle Kuykendall
No Relationships to Disclose
 
Evelina Reventaite
No Relationships to Disclose
 
Emma Filar
No Relationships to Disclose
 
Eliza Miller
No Relationships to Disclose
 
Benjamin A Yoder
No Relationships to Disclose
 
Angel Qin
Consulting or Advisory Role - Amgen
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Merck Sharp & Dohme (Inst); Roche (Inst); Takeda (Inst); Xencor (Inst)
 
Erin L. Schenk
Honoraria - Horizon CME; Horizon CME; Ideology Health; Janssen; MECC Global Meetings; MJH Life Sciences; OncLive; OncLive; Regeneron; Takeda
Consulting or Advisory Role - Actinium Pharmaceuticals; AstraZeneca; BioAtla; Bionest partners; ClearView Healthcare Partners; G1 Therapeutics; Guidepoint Global; Prescient Healthcare Group; Regeneron; Regeneron; The Scienomics Group